These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7741319)

  • 21. [Mechanisms of action of prostaglandin E1 in therapy of peripheral arterial occlusive diseases].
    Weiss T
    Vasa; 2003 Nov; 32(4):187-92. PubMed ID: 14694766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of clinical findings, positional manoeuvres, and systolic ankle arterial pressure on transcutaneous oxygen tension in peripheral arterial occlusive disease.
    Scheffler A; Eggert S; Rieger H
    Eur J Clin Invest; 1992 Jun; 22(6):420-6. PubMed ID: 1633837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T; Eckstein H; Weiss C; Diehm C
    Vasc Med; 1998; 3(3):171-5. PubMed ID: 9892509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
    Hesse WH; Rudofsky G; Peskar BA
    Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [CO2-induced acral blood flow and the oxygen partial pressure in arterial occlusive disease].
    Hartmann B; Drews B; Bassenge E
    Dtsch Med Wochenschr; 1991 Oct; 116(43):1617-21. PubMed ID: 1935632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of percutaneous transluminal angioplasty on transcutaneous oxygen pressure in patients with peripheral arterial occlusive disease.
    Wagner HJ; Schmitz R; Alfke H; Klose KJ
    Radiology; 2003 Mar; 226(3):791-7. PubMed ID: 12601207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcutaneous oxygen measurements in lower extremity ischemia: effects of position, oxygen inhalation, and arterial reconstruction.
    Moosa HH; Peitzman AB; Makaroun MS; Webster MW; Steed DL
    Surgery; 1988 Feb; 103(2):193-8. PubMed ID: 3340988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?].
    Breuer C; Abri O
    Vasa; 1995; 24(1):62-71. PubMed ID: 7536999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prostaglandin E1 in therapy of peripheral arterial occlusive disease].
    Sinzinger H; Rogatti W
    Wien Klin Wochenschr; 1991; 103(18):558-65. PubMed ID: 1750223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced alterations in muscle tissue oxygen pressure in patients with arterial occlusive disease.
    Creutzig A; Alexander K
    Int J Microcirc Clin Exp; 1985; 4(2):173-81. PubMed ID: 2412983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
    Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
    Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
    Creutzig A; Caspary L; Ranke C; Kiessling D; Wilkens J; Frölich J; Alexander K
    Vasa; 1987; 16(2):114-8. PubMed ID: 2955602
    [No Abstract]   [Full Text] [Related]  

  • 37. Forefoot transcutaneous oxygen tension at different leg positions in patients with peripheral vascular disease.
    Larsen JF; Jensen BV; Christensen KS; Egeblad K
    Eur J Vasc Surg; 1990 Apr; 4(2):185-9. PubMed ID: 2351219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
    Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
    Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia.
    Petrakis E; Sciacca V
    Int Angiol; 2000 Mar; 19(1):18-25. PubMed ID: 10853681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraarterial perfusion of prostaglandin E1 after lumbar sympathectomy or reconstruction on femoropopliteal segment.
    Davidovic LB; Vranes MR; Lotina SI; Cernak IF; Velimirovic DB; Stojanov PL; Sindjelic RP; Sagic DZ; Cinara IS
    Int Angiol; 1991; 10(3):178-81. PubMed ID: 1765722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.